9,10-phenanthrenequinone has been researched along with Colonic Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bao, M; Chen, Y; Guo, Y; Hong, K; Hu, W; Huang, J; Lei, J; Liu, Y; Xu, X; Zhang, Y | 1 |
1 other study(ies) available for 9,10-phenanthrenequinone and Colonic Neoplasms
Article | Year |
---|---|
Synthesis of dihydrofuran-3-one and 9,10-phenanthrenequinone hybrid molecules and biological evaluation against colon cancer cells as selective Akt kinase inhibitors.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Molecular Docking Simulation; Molecular Structure; Proto-Oncogene Proteins c-akt; Structure-Activity Relationship | 2023 |